Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR1 | P30872 | 3/20 | 0.50 |
| ▸ | SSTR2 | P30874 | 3/20 | 0.50 |
| ▸ | SSTR4 | P31391 | 3/20 | 0.50 |
| ▸ | SSTR3 | P32745 | 3/20 | 0.50 |
| ▸ | SSTR5 | P35346 | 3/20 | 0.50 |
| ▸ | TNF | P01375 | 2/20 | 0.42 |
| ▸ | GJB2 | P29033 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | FGF1 | P05230 | 3/20 | 0.32 |
| ▸ | FGF2 | P09038 | 3/20 | 0.32 |
| ▸ | VEGFA | P15692 | 3/20 | 0.32 |
| ▸ | HPSE | Q9Y251 | 3/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.32 |
| ▸ | TACR1 | P25103 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15304406 | 1.00 | SSTR1 (0.50) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL18542500 | 0.95 | SSTR1 (0.54) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL15981561 | 0.95 | SSTR1 (0.54) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL14045272 | 0.95 | SSTR1 (0.54) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL15886871 | 0.95 | SSTR1 (0.54) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL19356278 | 0.95 | SSTR1 (0.54) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL15679614 | 0.95 | SSTR1 (0.54) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL13605427 | 0.95 | SSTR1 (0.54) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL16770611 | 0.95 | SSTR1 (0.54) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL15505950 | 0.94 | SSTR1 (0.52) | SSTR1SSTR2SSTR4SSTR3SSTR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110104188-A1 | NOVEL GLYCOLIPID AND USE THEREOF | RIKEN (JP) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110104188-A1 | NOVEL GLYCOLIPID AND USE THEREOF | SGMS1, UGCG, SGPL1 | SSTR1 1064/4885SSTR2 1039/4885SSTR4 1340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.